Epinephrine Bitartrate, Lidocaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 10/14/2016. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-489-27
- Dosage Form
- Injection
- Presentation
- Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)
- Initial Posting
- 10/14/2016
- Revised Date
Reason
Other